GlycoMimetics Inc (GLYC)
2.28
+0.13
(+6.05%)
USD |
NASDAQ |
Apr 17, 16:00
2.280
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Cash from Financing (TTM): 28.82M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 28.82M |
September 30, 2023 | 32.98M |
June 30, 2023 | 32.92M |
March 31, 2023 | 32.90M |
December 31, 2022 | 4.157M |
September 30, 2022 | 1.140M |
June 30, 2022 | 1.160M |
March 31, 2022 | 1.160M |
December 31, 2021 | 10.72M |
September 30, 2021 | 13.47M |
June 30, 2021 | 18.00M |
March 31, 2021 | 27.58M |
December 31, 2020 | 18.14M |
September 30, 2020 | 14.38M |
June 30, 2020 | 10.02M |
March 31, 2020 | 0.5123M |
December 31, 2019 | 0.4129M |
September 30, 2019 | 0.4191M |
June 30, 2019 | 0.7371M |
March 31, 2019 | 0.5474M |
December 31, 2018 | 129.45M |
Date | Value |
---|---|
September 30, 2018 | 148.78M |
June 30, 2018 | 148.26M |
March 31, 2018 | 239.20M |
December 31, 2017 | 113.95M |
September 30, 2017 | 95.64M |
June 30, 2017 | 95.55M |
March 31, 2017 | 26.07M |
December 31, 2016 | 23.67M |
September 30, 2016 | 22.53M |
June 30, 2016 | 22.65M |
March 31, 2016 | 1.313M |
December 31, 2015 | 0.1141M |
September 30, 2015 | 0.1169M |
June 30, 2015 | 0.0971M |
March 31, 2015 | 0.2015M |
December 31, 2014 | 57.38M |
September 30, 2014 | 57.58M |
June 30, 2014 | 57.92M |
March 31, 2014 | 57.82M |
December 31, 2013 | 0.5589M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.4129M
Minimum
Dec 2019
32.98M
Maximum
Sep 2023
13.14M
Average
10.72M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
Altimmune Inc | 86.10M |
Cellectar Biosciences Inc | 22.94M |
PDS Biotechnology Corp | 16.38M |
Syros Pharmaceuticals Inc | 43.46M |
Precision BioSciences Inc | 5.387M |